{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:41:28Z","timestamp":1791096088677,"version":"4.1.0"},"reference-count":123,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.biopha.2006.09.002","type":"journal-article","created":{"date-parts":[[2006,10,11]],"date-time":"2006-10-11T07:38:46Z","timestamp":1160552326000},"page":"648-655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Autoantibodies in\u00a0rheumatoid arthritis: a\u00a0review"],"prefix":"10.1016","volume":"60","author":[{"given":"D.","family":"Mewar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.biopha.2006.09.002_bib1","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1056\/NEJMoa032534","article-title":"Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis","volume":"350","author":"Edwards","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.biopha.2006.09.002_bib2","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/1529-0131(199912)42:12<2499::AID-ANR1>3.0.CO;2-R","article-title":"The immunologic homunculus in rheumatoid arthritis","volume":"42","author":"Blass","year":"1999","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.biopha.2006.09.002_bib3","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.it.2005.05.007","article-title":"Understanding crypticity is the key to revealing the pathogenesis of autoimmunity","volume":"26","author":"Moudgil","year":"2005","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2006.09.002_bib4","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/1529-0131(200003)43:3<473::AID-ANR1>3.0.CO;2-A","article-title":"When does rheumatoid arthritis begin and why do we need to know?","volume":"43","author":"Kim","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.biopha.2006.09.002_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.biopha.2006.09.002_bib6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/1529-0131(200104)44:4<761::AID-ANR132>3.0.CO;2-S","article-title":"The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis","volume":"44","author":"Blass","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.biopha.2006.09.002_bib7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1699-0463.1940.tb01475.x","article-title":"On the occurrence of a factor in human serum activating the specific agglutination of sheep blood corpuscles","volume":"17","author":"Waaler","year":"1940","journal-title":"Acta Pathol. Microbiol. Scand."},{"key":"10.1016\/j.biopha.2006.09.002_bib8","series-title":"Kelley\u2019s textbook of rheumatology","first-page":"151","article-title":"Rheumatoid factor","author":"Tighe","year":"2001"},{"issue":"3","key":"10.1016\/j.biopha.2006.09.002_bib9","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/eji.1830270323","article-title":"Differences in mutational patterns between rheumatoid factors in health and disease are related to variable heavy chain family and germ-line gene usage","volume":"27","author":"Borretzen","year":"1997","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2006.09.002_bib10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4049\/jimmunol.151.1.473","article-title":"Human rheumatoid B-1a (CD5+ B) cells make somatically hypermutated high affinity IgM rheumatoid factors","volume":"151","author":"Mantovani","year":"1993","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2006.09.002_bib11","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1084\/jem.181.2.599","article-title":"Human immunoglobulin (IgG) induced deletion of IgM rheumatoid factor B cells in transgenic mice","volume":"181","author":"Tighe","year":"1995","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.biopha.2006.09.002_bib12","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.4049\/jimmunol.163.6.3116","article-title":"Human rheumatoid factor production is dependent on CD40 signaling and autoantigen","volume":"163","author":"Kyburz","year":"1999","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2006.09.002_bib13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-2249.1997.4061306.x","article-title":"Expression of molecules involved in B lymphocyte survival and differentiation by synovial fibroblasts","volume":"108","author":"Edwards","year":"1997","journal-title":"Clin. Exp. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2006.09.002_bib14","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/ard.54.9.696","article-title":"Is rheumatoid arthritis a failure of B cell death in synovium?","volume":"54","author":"Edwards","year":"1995","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2006.09.002_bib15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/rheumatology\/37.2.126","article-title":"Rheumatoid arthritis: the predictable effect of small immune complexes in which antibody is also antigen","volume":"37","author":"Edwards","year":"1998","journal-title":"Br. J. Rheumatol."},{"issue":"9","key":"10.1016\/j.biopha.2006.09.002_bib16","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.1780250911","article-title":"Human complement activation by self-associated IgG rheumatoid factors","volume":"25","author":"Brown","year":"1982","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.biopha.2006.09.002_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1084\/jem.177.1.109","article-title":"Function of B cells expressing a human immunoglobulin M rheumatoid factor autoantibody in transgenic mice","volume":"177","author":"Tighe","year":"1993","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.biopha.2006.09.002_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0049-0172(76)90013-5","article-title":"Prospective study of the early course of rheumatoid arthritis in young adults: comparison of patients with and without rheumatoid factor positivity at entry and identification of variables correlating with outcome","volume":"4","author":"Masi","year":"1976","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.biopha.2006.09.002_bib19","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/ard.23.4.302","article-title":"A new serum factor in patients with rheumatoid arthritis. The antiperinuclear factor","volume":"23","author":"Nienhuis","year":"1964","journal-title":"Ann. Rheum. Dis."},{"issue":"6182","key":"10.1016\/j.biopha.2006.09.002_bib20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/bmj.2.6182.97","article-title":"Anti-keratin antibodies in rheumatoid arthritis","volume":"2","author":"Young","year":"1979","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.biopha.2006.09.002_bib21","first-page":"1027","article-title":"The Sa system: a novel antigen\u2013antibody system specific for rheumatoid arthritis","volume":"21","author":"Despres","year":"1994","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.biopha.2006.09.002_bib22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.biopha.2006.09.002_bib23","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI117969","article-title":"The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies","volume":"95","author":"Sebbag","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.biopha.2006.09.002_bib24","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1172\/JCI116713","article-title":"The cytokeratin filament-aggregating protein filaggrin is the target of the so-called \u201cantikeratin antibodies,\u201d autoantibodies specific for rheumatoid arthritis","volume":"92","author":"Simon","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.biopha.2006.09.002_bib25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4049\/jimmunol.162.1.585","article-title":"The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues","volume":"162","author":"Girbal-Neuhauser","year":"1999","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2006.09.002_bib26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/ar122","article-title":"Insights into rheumatoid arthritis derived from the Sa immune system","volume":"2","author":"Menard","year":"2000","journal-title":"Arthritis Res."},{"issue":"2","key":"10.1016\/j.biopha.2006.09.002_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/rheumatology\/38.2.155","article-title":"Sensitivity and specificity of anti-Sa autoantibodies for rheumatoid arthritis","volume":"38","author":"Hueber","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.biopha.2006.09.002_bib28","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/ar93","article-title":"Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset","volume":"2","author":"Goldbach-Mansky","year":"2000","journal-title":"Arthritis Res."},{"issue":"6","key":"10.1016\/j.biopha.2006.09.002_bib29","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.4049\/jimmunol.166.6.4177","article-title":"The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin","volume":"166","author":"Masson-Bessiere","year":"2001","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2006.09.002_bib30","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1136\/ard.2005.044743","article-title":"Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids","volume":"65","author":"Takizawa","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2006.09.002_bib31","doi-asserted-by":"crossref","first-page":"R1421","DOI":"10.1186\/ar1845","article-title":"Identification of citrullinated alpha-enolase as a candidate autoantigen in rheumatoid arthritis","volume":"7","author":"Kinloch","year":"2005","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2006.09.002_bib32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bbrc.2005.12.160","article-title":"Identification of citrullinated eukaryotic translation initiation factor 4G1 as novel autoantigen in rheumatoid arthritis","volume":"341","author":"Okazaki","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.biopha.2006.09.002_bib33","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1136\/ard.2004.031211","article-title":"Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?","volume":"64","author":"Koivula","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.biopha.2006.09.002_bib34","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1002\/1529-0131(200110)44:10<2255::AID-ART388>3.0.CO;2-#","article-title":"Specific presence of intracellular citrullinated proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies","volume":"44","author":"Baeten","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.biopha.2006.09.002_bib35","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/art.20584","article-title":"The presence of citrullinated proteins is not specific for rheumatoid synovial tissue","volume":"50","author":"Vossenaar","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.biopha.2006.09.002_bib36","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1002\/art.11229","article-title":"Citrullination of synovial proteins in murine models of rheumatoid arthritis","volume":"48","author":"Vossenaar","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.biopha.2006.09.002_bib37","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/art.20296","article-title":"Absence of citrulline-specific autoantibodies in animal models of autoimmunity","volume":"50","author":"Vossenaar","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.biopha.2006.09.002_bib38","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI25422","article-title":"Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis","volume":"116","author":"Kuhn","year":"2006","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.biopha.2006.09.002_bib39","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/rheumatology\/33.4.336","article-title":"The prevalence of serum IgG antibodies to type II collagen in American patients with rheumatoid arthritis","volume":"33","author":"Clague","year":"1994","journal-title":"Br. J. Rheumatol."},{"issue":"12","key":"10.1016\/j.biopha.2006.09.002_bib40","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/ard.46.12.902","article-title":"Incidence of antibodies to native and denatured cartilage collagens (types II, IX, and XI) and to type I collagen in rheumatoid arthritis","volume":"46","author":"Morgan","year":"1987","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.biopha.2006.09.002_bib41","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/art.1780271207","article-title":"IgG and IgM antibody to native type II collagen in rheumatoid arthritis serum and synovial fluid. Evidence for the presence of collagen\u2013anticollagen immune complexes in synovial fluid","volume":"27","author":"Clague","year":"1984","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.biopha.2006.09.002_bib42","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/1521-4141(200106)31:6<1666::AID-IMMU1666>3.0.CO;2-T","article-title":"Cartilage-specific autoimmunity in rheumatoid arthritis: characterization of a triple helical B cell epitope in the integrin-binding-domain of collagen type II","volume":"31","author":"Kraetsch","year":"2001","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.biopha.2006.09.002_bib43","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/1529-0131(199707)40:7<1210::AID-ART4>3.0.CO;2-T","article-title":"T cell responses to human type II collagen in patients with rheumatoid arthritis and healthy controls","volume":"40","author":"Snowden","year":"1997","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.biopha.2006.09.002_bib44","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/art.1780391015","article-title":"Antibodies to type II collagen in early rheumatoid arthritis. Correlation with disease progression","volume":"39","author":"Cook","year":"1996","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.biopha.2006.09.002_bib45","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/1529-0131(199802)41:2<290::AID-ART13>3.0.CO;2-R","article-title":"Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial","volume":"41","author":"Barnett","year":"1998","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.biopha.2006.09.002_bib46","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/anr.1780321204","article-title":"Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis","volume":"32","author":"Hassfeld","year":"1989","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.biopha.2006.09.002_bib47","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/art.1780380610","article-title":"Autoimmune response to the spliceosome. An immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus","volume":"38","author":"Hassfeld","year":"1995","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.biopha.2006.09.002_bib48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1172\/JCI119504","volume":"100","author":"Skriner","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.biopha.2006.09.002_bib49","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.4049\/jimmunol.175.12.8327","article-title":"Aberrant expression of the autoantigen heterogeneous nuclear ribonucleoprotein-A2 (RA33) and spontaneous formation of rheumatoid arthritis-associated anti-RA33 autoantibodies in TNF-alpha transgenic mice","volume":"175","author":"Hayer","year":"2005","journal-title":"J. Immunol."},{"issue":"Suppl","key":"10.1016\/j.biopha.2006.09.002_bib50","article-title":"Anti-A2\/RA33 autoantibodies in animal models of rheumatoid arthritis and SLE (abstract)","volume":"40","author":"Steiner","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.biopha.2006.09.002_bib51","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/rheumatology\/37.4.421","article-title":"Erosive arthritis in systemic lupus erythematosus: analysis of a distinct clinical and serological subset","volume":"37","author":"Richter Cohen","year":"1998","journal-title":"Br. J. Rheumatol."},{"issue":"6","key":"10.1016\/j.biopha.2006.09.002_bib52","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1136\/ard.54.6.477","article-title":"Appearance of calpain correlates with arthritis and cartilage destruction in collagen induced arthritic knee joints of mice","volume":"54","author":"Szomor","year":"1995","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.biopha.2006.09.002_bib53","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/art.1780351111","article-title":"Calcium-dependent cysteine proteinase (calpain) in human arthritic synovial joints","volume":"35","author":"Yamamoto","year":"1992","journal-title":"Arthritis Rheum."},{"issue":"Pt 3","key":"10.1016\/j.biopha.2006.09.002_bib54","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1042\/bj2850857","article-title":"Characterization of proteoglycan degradation by calpain","volume":"285","author":"Suzuki","year":"1992","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.biopha.2006.09.002_bib55","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1172\/JCI117870","article-title":"Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera","volume":"95","author":"Despres","year":"1995","journal-title":"J. Clin. Invest."},{"issue":"16","key":"10.1016\/j.biopha.2006.09.002_bib56","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1073\/pnas.92.16.7267","article-title":"Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases","volume":"92","author":"Mimori","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.biopha.2006.09.002_bib57","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0167-5699(96)30064-9","article-title":"The calpain\u2013calpastatin system in rheumatoid arthritis","volume":"17","author":"Menard","year":"1996","journal-title":"Immunol. Today"},{"issue":"11","key":"10.1016\/j.biopha.2006.09.002_bib58","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/rheumatology\/37.11.1164","article-title":"Autoantibodies against human calpastatin in rheumatoid arthritis: epitope mapping and analysis of patient sera","volume":"37","author":"Lackner","year":"1998","journal-title":"Br. J. Rheumatol."},{"issue":"3","key":"10.1016\/j.biopha.2006.09.002_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399401003556","article-title":"Heat shock proteins in health and disease: therapeutic targets or therapeutic agents?","author":"Pockley","year":"2001","journal-title":"Expert. Rev. Mol. Med."},{"issue":"2","key":"10.1016\/j.biopha.2006.09.002_bib60","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0049-0172(96)80043-6","article-title":"Anti-heat-shock protein antibodies in rheumatic and autoimmune diseases","volume":"26","author":"Tishler","year":"1996","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.biopha.2006.09.002_bib61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1600-065X.1998.tb01219.x","article-title":"Diversification of response to hsp65 during the course of autoimmune arthritis is regulatory rather than pathogenic","volume":"164","author":"Moudgil","year":"1998","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.biopha.2006.09.002_bib62","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/ard.56.5.317","article-title":"Rheumatoid arthritis: autoreactive T cells recognising a novel 68\u00a0kDa autoantigen","volume":"56","author":"Blass","year":"1997","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2006.09.002_bib63","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/ard.57.4.220","article-title":"The p68 autoantigen characteristic of rheumatoid arthritis is reactive with carbohydrate epitope specific autoantibodies","volume":"57","author":"Blass","year":"1998","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.biopha.2006.09.002_bib64","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/ard.54.5.355","article-title":"Novel 68\u00a0kDa autoantigen detected by rheumatoid arthritis specific antibodies","volume":"54","author":"Blass","year":"1995","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.biopha.2006.09.002_bib65","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.4049\/jimmunol.166.3.1492","article-title":"The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis","volume":"166","author":"Corrigall","year":"2001","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2006.09.002_bib66","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/rheumatology\/keh312","article-title":"Antibody response to the human stress protein BiP in rheumatoid arthritis","volume":"43","author":"Bodman-Smith","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.biopha.2006.09.002_bib67","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/rheumatology\/keg204","article-title":"BiP, a putative autoantigen in rheumatoid arthritis, stimulates IL-10-producing CD8-positive T cells from normal individuals","volume":"42","author":"Bodman-Smith","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.biopha.2006.09.002_bib68","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/art.20134","article-title":"Inhibition of antigen-presenting cell function and stimulation of human peripheral blood mononuclear cells to express an antiinflammatory cytokine profile by the stress protein BiP: relevance to the treatment of inflammatory arthritis","volume":"50","author":"Corrigall","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.biopha.2006.09.002_bib69","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1053\/gast.2001.20223","article-title":"Autoantibodies in liver disease","volume":"120","author":"Czaja","year":"2001","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.biopha.2006.09.002_bib70","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/00002281-200011000-00001","article-title":"Update on myositis-specific and myositis-associated autoantibodies","volume":"12","author":"Targoff","year":"2000","journal-title":"Curr. Opin. Rheumatol."},{"issue":"4","key":"10.1016\/j.biopha.2006.09.002_bib71","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/art.1780390412","article-title":"Reduction in long-term disability in patients with rheumatoid arthritis by disease-modifying antirheumatic drug-based treatment strategies","volume":"39","author":"Fries","year":"1996","journal-title":"Arthritis Rheum."},{"issue":"11","key":"10.1016\/j.biopha.2006.09.002_bib72","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/rheumatology\/37.11.1157","article-title":"Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression","volume":"37","author":"Stenger","year":"1998","journal-title":"Br. J. Rheumatol."},{"issue":"10","key":"10.1016\/j.biopha.2006.09.002_bib73","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1136\/ard.2004.035089","article-title":"A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis","volume":"64","author":"van Gaalen","year":"2005","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.biopha.2006.09.002_bib74","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/ard.2006.051391","article-title":"Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review","volume":"65","author":"Avouac","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.biopha.2006.09.002_bib75","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1002\/art.21483","article-title":"Antiferritin antibodies discovered by phage display expression cloning are associated with radiographic damage in rheumatoid arthritis","volume":"52","author":"Mewar","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.biopha.2006.09.002_bib76","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/ard.61.7.598","article-title":"Autoantibodies against interleukin 1alpha in rheumatoid arthritis: association with long term radiographic outcome","volume":"61","author":"Graudal","year":"2002","journal-title":"Ann. Rheum. Dis."},{"issue":"9","key":"10.1016\/j.biopha.2006.09.002_bib77","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/art.21269","article-title":"Antigen microarray profiling of autoantibodies in rheumatoid arthritis","volume":"52","author":"Hueber","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.biopha.2006.09.002_bib78","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/eji.200324201","article-title":"Characterization of novel antigens recognized by serum autoantibodies from anti-CD1 TCR-transgenic lupus mice","volume":"34","author":"Hueber","year":"2004","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2006.09.002_bib79","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/art.1780280503","article-title":"When does rheumatoid disease start?","volume":"28","author":"Aho","year":"1985","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.biopha.2006.09.002_bib80","first-page":"1282","article-title":"Rheumatoid factors antedating clinical rheumatoid arthritis","volume":"18","author":"Aho","year":"1991","journal-title":"J. Rheumatol."},{"issue":"8","key":"10.1016\/j.biopha.2006.09.002_bib81","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.1780350810","article-title":"Immunopathology of rheumatoid arthritis. Antikeratin antibodies precede the clinical disease","volume":"35","author":"Kurki","year":"1992","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.biopha.2006.09.002_bib82","first-page":"1278","article-title":"Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process","volume":"20","author":"Aho","year":"1993","journal-title":"J. Rheumatol."},{"issue":"12","key":"10.1016\/j.biopha.2006.09.002_bib83","first-page":"2743","article-title":"Antifilaggrin antibodies within \u201cnormal\u201d range predict rheumatoid arthritis in a linear fashion","volume":"27","author":"Aho","year":"2000","journal-title":"J. Rheumatol."},{"issue":"10","key":"10.1016\/j.biopha.2006.09.002_bib84","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.biopha.2006.09.002_bib85","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.biopha.2006.09.002_bib86","doi-asserted-by":"crossref","first-page":"R303","DOI":"10.1186\/ar1187","article-title":"A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis","volume":"6","author":"Berglin","year":"2004","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2006.09.002_bib87","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1186\/ar1868","article-title":"PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease","volume":"8","author":"Johansson","year":"2005","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2006.09.002_bib88","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1084\/jem.146.3.857","article-title":"Autoimmunity to type II collagen an experimental model of arthritis","volume":"146","author":"Trentham","year":"1977","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.biopha.2006.09.002_bib89","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/art.1780300418","article-title":"Passive transfer studies with type II collagen antibody in B10.D2\/old and new line and C57Bl\/6 normal and beige (Chediak\u2013Higashi) strains: evidence of important roles for C5 and multiple inflammatory cell types in the development of erosive arthritis","volume":"30","author":"Watson","year":"1987","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.biopha.2006.09.002_bib90","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1084\/jem.154.3.688","article-title":"Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates","volume":"154","author":"Wooley","year":"1981","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.biopha.2006.09.002_bib91","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/08916930008995984","article-title":"Relapsing arthritis induced by cell transfer from collagen-immunised mice","volume":"32","author":"Hesse","year":"2000","journal-title":"Autoimmunity"},{"issue":"2","key":"10.1016\/j.biopha.2006.09.002_bib92","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2249.1994.tb06070.x","article-title":"CD4+ T cells from collagen-induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice","volume":"97","author":"Kadowaki","year":"1994","journal-title":"Clin. Exp. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2006.09.002_bib93","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.4049\/jimmunol.168.8.4164","article-title":"Depletion of collagen II-reactive T cells and blocking of B cell activation prevents collagen II-induced arthritis in DBA\/1j mice","volume":"168","author":"Zhang","year":"2002","journal-title":"J. Immunol."},{"issue":"19","key":"10.1016\/j.biopha.2006.09.002_bib94","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0024-3205(97)00480-3","article-title":"Collagen-induced arthritis, an animal model of autoimmunity","volume":"61","author":"Myers","year":"1997","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.biopha.2006.09.002_bib95","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0092-8674(00)81989-3","article-title":"Organ-specific disease provoked by systemic autoimmunity","volume":"87","author":"Kouskoff","year":"1996","journal-title":"Cell"},{"issue":"5445","key":"10.1016\/j.biopha.2006.09.002_bib96","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1126\/science.286.5445.1732","article-title":"Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme","volume":"286","author":"Matsumoto","year":"1999","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.biopha.2006.09.002_bib97","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/ni772","article-title":"How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease","volume":"3","author":"Matsumoto","year":"2002","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2006.09.002_bib98","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1172\/JCI16015","article-title":"Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis","volume":"111","author":"Dong","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.biopha.2006.09.002_bib99","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1172\/JCI7479","article-title":"Cloning of novel soluble gp130 and detection of its neutralizing autoantibodies in rheumatoid arthritis","volume":"106","author":"Tanaka","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.biopha.2006.09.002_bib100","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.189.10.1639","article-title":"A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus","volume":"189","author":"Chan","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biopha.2006.09.002_bib101","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-065X.1998.tb01223.x","article-title":"Epitope spreading: the role of self peptides and autoantigen processing by B lymphocytes","volume":"164","author":"Mamula","year":"1998","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2006.09.002_bib102","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1084\/jem.173.2.487","article-title":"Efficient and selective presentation of antigen\u2013antibody complexes by rheumatoid factor B cells","volume":"173","author":"Roosnek","year":"1991","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.biopha.2006.09.002_bib103","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.4049\/jimmunol.165.3.1626","article-title":"Immune complexes present in the sera of autoimmune mice activate rheumatoid factor B cells","volume":"165","author":"Rifkin","year":"2000","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2006.09.002_bib104","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/35100573","article-title":"From T to B and back again: positive feedback in systemic autoimmune disease","volume":"1","author":"Shlomchik","year":"2001","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2006.09.002_bib105","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1002\/art.11224","article-title":"Can we accurately predict the development of rheumatoid arthritis in the preclinical phase?","volume":"48","author":"Majka","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.biopha.2006.09.002_bib106","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0167-5699(97)01053-0","article-title":"Oral tolerance: immune mechanisms and treatment of autoimmune diseases","volume":"18","author":"Weiner","year":"1997","journal-title":"Immunol. Today"},{"issue":"6","key":"10.1016\/j.biopha.2006.09.002_bib107","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/1529-0131(199906)42:6<1204::AID-ANR17>3.0.CO;2-U","article-title":"Lack of efficacy of oral bovine type II collagen added to existing therapy in rheumatoid arthritis","volume":"42","author":"McKown","year":"1999","journal-title":"Arthritis Rheum."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2006.09.002_bib108","first-page":"619","article-title":"Update on major trials for the prevention of type 1 diabetes mellitus: the American Diabetes Prevention Trial (DPT-1) and the European Nicotinamide Diabetes Intervention Trial (ENDIT)","volume":"14","author":"Schatz","year":"2001","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.biopha.2006.09.002_bib109","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF00217522","article-title":"Analysis of autoantibodies to plasminogen in the serum of patients with rheumatoid arthritis","volume":"74","author":"Gonzalez-Gronow","year":"1996","journal-title":"J. Mol. Med."},{"issue":"16","key":"10.1016\/j.biopha.2006.09.002_bib110","doi-asserted-by":"crossref","first-page":"9234","DOI":"10.1073\/pnas.97.16.9234","article-title":"Cloning and expression of a novel human antibody\u2013antigen pair associated with Felty\u2019s syndrome","volume":"97","author":"Ditzel","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.biopha.2006.09.002_bib111","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/030097401300162950","article-title":"Anti-IL-1alpha autoantibodies in early rheumatoid arthritis","volume":"30","author":"Forslind","year":"2001","journal-title":"Scand. J. Rheumatol."},{"issue":"1","key":"10.1016\/j.biopha.2006.09.002_bib112","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard.51.1.19","article-title":"Human neutrophil activating peptide\/interleukin 8 acts as an autoantigen in rheumatoid arthritis","volume":"51","author":"Peichl","year":"1992","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.biopha.2006.09.002_bib113","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s002960050073","article-title":"Anti-IL-8 autoantibodies and complexes in rheumatoid arthritis: polyclonal activation in chronic synovial tissue inflammation","volume":"18","author":"Peichl","year":"1999","journal-title":"Rheumatol. Int."},{"issue":"5","key":"10.1016\/j.biopha.2006.09.002_bib114","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/art.10252","article-title":"Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis","volume":"46","author":"Saulot","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.biopha.2006.09.002_bib115","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/ard.58.3.169","article-title":"Serum samples of patients with rheumatoid arthritis contain a specific autoantibody to \u201cdenatured\u201d aldolase A in the osteoblast-like cell line, MG-63","volume":"58","author":"Ukaji","year":"1999","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.biopha.2006.09.002_bib116","first-page":"673","article-title":"Characterization of human serum dipeptidyl peptidase IV (CD26) and analysis of its autoantibodies in patients with rheumatoid arthritis and other autoimmune diseases","volume":"19","author":"Cuchacovich","year":"2001","journal-title":"Clin. Exp. Rheumatol."},{"issue":"7","key":"10.1016\/j.biopha.2006.09.002_bib117","first-page":"1492","article-title":"Autoantibodies to osteopontin in patients with osteoarthritis and rheumatoid arthritis","volume":"28","author":"Sakata","year":"2001","journal-title":"J. Rheumatol."},{"issue":"8","key":"10.1016\/j.biopha.2006.09.002_bib118","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/90696","article-title":"Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease","volume":"2","author":"Schaller","year":"2001","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2006.09.002_bib119","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/rheumatology\/keg271","article-title":"Glucose-6-phosphate isomerase is not a specific autoantigen in rheumatoid arthritis","volume":"42","author":"Herve","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.biopha.2006.09.002_bib120","first-page":"1668","article-title":"Autoantibodies to lipocortin-1 are associated with impaired glucocorticoid responsiveness in rheumatoid arthritis","volume":"19","author":"Podgorski","year":"1992","journal-title":"J. Rheumatol."},{"issue":"10","key":"10.1016\/j.biopha.2006.09.002_bib121","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/ard.48.10.843","article-title":"Autoantibodies to recombinant lipocortin-1 in rheumatoid arthritis and systemic lupus erythematosus","volume":"48","author":"Goulding","year":"1989","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2006.09.002_bib122","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2249.1997.tb08324.x","article-title":"Specificities of anti-neutrophil autoantibodies in patients with rheumatoid arthritis (RA)","volume":"110","author":"Brimnes","year":"1997","journal-title":"Clin. Exp. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2006.09.002_bib123","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1136\/ard.59.11.898","article-title":"Characterisation of autoantibodies to neutrophil granule constituents among patients with reactive arthritis, rheumatoid arthritis, and ulcerative colitis","volume":"59","author":"Locht","year":"2000","journal-title":"Ann. Rheum. Dis."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332206002873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332206002873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:37:27Z","timestamp":1760092647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332206002873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":123,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0753332206002873"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2006.09.002","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies in\u00a0rheumatoid arthritis: a\u00a0review","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2006.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}